|Title:||Frequent mutations that converge on the NFKBIZ pathway in ulcerative colitis|
|Authors:||Kakiuchi, Nobuyuki https://orcid.org/0000-0003-4893-5414 (unconfirmed)|
Ochi, Yotaro https://orcid.org/0000-0001-8472-6164 (unconfirmed)
Kim, Soo Ki
Kon, Ayana https://orcid.org/0000-0001-7237-0180 (unconfirmed)
Nakagawa, Masahiro M.
Taketo, Makoto Mark
Takeuchi, Osamu https://orcid.org/0000-0002-1260-6232 (unconfirmed)
|Author's alias:||垣内, 伸之|
|Abstract:||Chronic inflammation is accompanied by recurring cycles of tissue destruction and repair and is associated with an increased risk of cancer1, 2, 3. However, how such cycles affect the clonal composition of tissues, particularly in terms of cancer development, remains unknown. Here we show that in patients with ulcerative colitis, the inflamed intestine undergoes widespread remodelling by pervasive clones, many of which are positively selected by acquiring mutations that commonly involve the NFKBIZ, TRAF3IP2, ZC3H12A, PIGR and HNRNPF genes and are implicated in the downregulation of IL-17 and other pro-inflammatory signals. Mutational profiles vary substantially between colitis-associated cancer and non-dysplastic tissues in ulcerative colitis, which indicates that there are distinct mechanisms of positive selection in both tissues. In particular, mutations in NFKBIZ are highly prevalent in the epithelium of patients with ulcerative colitis but rarely found in both sporadic and colitis-associated cancer, indicating that NFKBIZ-mutant cells are selected against during colorectal carcinogenesis. In further support of this negative selection, we found that tumour formation was significantly attenuated in Nfkbiz-mutant mice and cell competition was compromised by disruption of NFKBIZ in human colorectal cancer cells. Our results highlight common and discrete mechanisms of clonal selection in inflammatory tissues, which reveal unexpected cancer vulnerabilities that could potentially be exploited for therapeutics in colorectal cancer.|
|Description:||潰瘍性大腸炎による上皮再構築メカニズムと発がんとの関係を解明 --IL-17シグナル経路に変異を獲得した上皮細胞は発がん過程で陰性に選択される--. 京都大学プレスリリース. 2019-12-20.|
|Rights:||This is the accepted manuscript of the article, which has been published in final form at https://doi.org/10.1038/s41586-019-1856-1.|
The full-text file will be made open to the public on 18 June 2020 in accordance with publisher's 'Terms and Conditions for Self-Archiving'.
This is not the published version. Please cite only the published version. この論文は出版社版でありません。引用の際には出版社版をご確認ご利用ください。
|Appears in Collections:||Journal Articles |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.